Vitamin D During Pregnancy

This study is currently recruiting participants.

Verified March 2012 by Hadassah Medical Organization

Sponsor:

Information provided by (Responsible Party):

Hadassah Medical Organization

ClinicalTrials.gov Identifier:

NCT01589783

First received: April 1, 2012

Last updated: November 7, 2012

Last verified: March 2012

History of Changes

Purpose

Vitamin D insufficiency is common globally. Pregnant women, who need an increased supply of this vitamin for the proper development of the fetus, are a significant risk group. The purpose of this study is to examine which factors - education, knowledge from non-professional sources, recommendations from medical staff - influence the use of vitamin D among pregnant women in light of the lack of a clear health policy, and to help formulating guidelines for a new health policy with specific recommendations for vitamin D dosage in pregnancy.

Condition	Intervention
Vitamin D Deficiency	Other: completion of a questionnaire Other: Blood draw

Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Cross-Sectional
Official Title:	Evaluation of the Influence of Education, Knowledge and Existing Guidelines on the Consumption of Vitamin D During Pregnancy.

Resource links provided by NLM:

MedlinePlus related topics: Vitamin D

Drug Information available for: Vitamin D

U.S. FDA Resources

Further study details as provided by Hadassah Medical Organization:

Primary Outcome Measures:

Use of Vitamin D in Pregnant Women [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Estimated Enrollment:	825
Study Start Date:	May 2012

Groups/Cohorts	Assigned Interventions
Pregnant or newly post partum women	Other: completion of a questionnaire Completion of a questionnaire Other: Blood draw A subset of 100 women will have a blood test to measure Vitamin D levels
family practice physicians and obstetricians	Other: completion of a questionnaire Completion of a questionnaire

Eligibility

Ages Eligible for Study:	18 Years to 50 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

We are recruiting either pregnant women or those who just gave birth (and still hospitalized) and a group of both family practice physicians and obstertricians.

Criteria

Inclusion Criteria for the pregnant of newly post-partum women:

women between 18-50
pregnant or just given birth and still hospitalized
understand and can read Hebrew

Exclusion Criteria:

those who do not understand or read Hebrew

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01589783

Contacts

Contact: Drorith Hochner, MD

00 972 2 5844600

hochner@hadassah.org.il

Locations

Israel
Hadassah Medical Organization	Recruiting
Jerusalem, Israel
Contact: Hadas Lamberg, PhD 00 972 2 6777572 lhadas@hadassah.org.il

Sponsors and Collaborators

Hadassah Medical Organization

Investigators

Principal Investigator:

Drorith Hochner, MD

Hadassah Medical Organization

More Information

No publications provided

Responsible Party:	Hadassah Medical Organization
ClinicalTrials.gov Identifier:	NCT01589783 History of Changes
Other Study ID Numbers:	VitDand Preg-HMO-CTIL
Study First Received:	April 1, 2012
Last Updated:	November 7, 2012
Health Authority:	Israel: Ministry of Health

Keywords provided by Hadassah Medical Organization:

Pregnancy
Vitamin D

Additional relevant MeSH terms:

Vitamin D Deficiency
Avitaminosis
Deficiency Diseases
Malnutrition
Nutrition Disorders
Vitamin D
Ergocalciferols

Vitamins
Bone Density Conservation Agents
Physiological Effects of Drugs
Pharmacologic Actions
Micronutrients
Growth Substances

ClinicalTrials.gov processed this record on May 16, 2013

To Top